Zydus Lifesciences Ltd s subsidiary Zydus Pharmaceuticals USA Inc. has received final approval for Tofacitinib Tablets, 5 mg and tentative approval for Tofacitinib Tablets, 10 mg from the United States Food and Drug Administration.
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration for Lenalidomide Capsules, 2.5 mg and 20 mg.
Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) for Vigabatrin for Oral Solution USP, 500 mg.